BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Porfimer Sodium readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Porfimer Sodium\, from ClinicalTrials.gov
  estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT02153229-2173@assetmemo.bio
DTSTAMP:20261121T005734Z
DTSTART;VALUE=DATE:20261216
DTEND;VALUE=DATE:20261217
SUMMARY:Porfimer Sodium: Phase 2 readout est. (NCT02153229)
DESCRIPTION:Porfimer Sodium\, phase 2.\nStudy: Phase II Trial of Radical Pl
 eurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothe
 lioma\nEstimated primary completion: 16 December 2026. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/porfimer-sodium#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT02153229
URL:https://assetmemo.bio/drug/porfimer-sodium#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
